Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EBT (2016 - 2025)

Historic EBT for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$53.9 million.

  • Wave Life Sciences' EBT rose 1283.26% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 1443.41%. This contributed to the annual value of -$97.0 million for FY2024, which is 6670.91% down from last year.
  • According to the latest figures from Q3 2025, Wave Life Sciences' EBT is -$53.9 million, which was up 1283.26% from -$50.5 million recorded in Q2 2025.
  • Wave Life Sciences' EBT's 5-year high stood at $29.3 million during Q4 2024, with a 5-year trough of -$61.8 million in Q3 2024.
  • Moreover, its 5-year median value for EBT was -$37.8 million (2022), whereas its average is -$31.1 million.
  • Within the past 5 years, the most significant YoY rise in Wave Life Sciences' EBT was 27995.2% (2024), while the steepest drop was 103961.98% (2024).
  • Quarter analysis of 5 years shows Wave Life Sciences' EBT stood at -$35.0 million in 2021, then fell by 22.98% to -$43.0 million in 2022, then skyrocketed by 62.22% to -$16.3 million in 2023, then soared by 279.95% to $29.3 million in 2024, then tumbled by 284.09% to -$53.9 million in 2025.
  • Its last three reported values are -$53.9 million in Q3 2025, -$50.5 million for Q2 2025, and -$46.9 million during Q1 2025.